Dexcom (DXCM) Change in Accured Expenses (2010 - 2026)
Dexcom (DXCM) posted quarterly Change in Accured Expenses of $112.9 million for Q2 2026, down 51.75% year-over-year from $234.0 million in Q2 2025, and down 22.19% quarter-over-quarter from $145.1 million in Q1 2026.
Dexcom (DXCM) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Change in Accured Expenses for 17 consecutive years, with $112.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Accured Expenses fell 51.75% year-over-year to $112.9 million; the TTM figure through Jun 2026 stood at $245.6 million (down 36.9% YoY), while the FY2025 annual figure was $347.0 million, up 63.91% from the prior year.
- Change in Accured Expenses eased to $112.9 million in Q2 2026 per DXCM's latest filing, from $145.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $234.0 million in Q2 2025 and bottomed at -$30.0 million in Q4 2023.
- Historically, Change in Accured Expenses has averaged $87.7 million across 5 years, with a median of $81.0 million in 2022.
- On a YoY basis, Change in Accured Expenses climbed as much as 347.76% in 2023 and fell as far as 124.23% in 2023.
- Dexcom's Change in Accured Expenses stood at $123.8 million in 2022, then tumbled by 124.23% to -$30.0 million in 2023, then jumped by 33.33% to -$20.0 million in 2024, then jumped by 49.5% to -$10.1 million in 2025, then soared by 1217.82% to $112.9 million in 2026.
- Business Quant data shows DXCM's Change in Accured Expenses at $112.9 million in Q2 2026, $145.1 million in Q1 2026, and -$10.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn | 92.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.90 Mn |
| Jun 30, 2026 | 112.90 Mn |
| Mar 31, 2026 | 145.10 Mn |
| Mar 31, 2026 | 145.10 Mn |
| Dec 31, 2025 | -1.20 Mn |
| Dec 31, 2025 | -1.20 Mn |
| Sep 30, 2025 | 41.30 Mn |
| Sep 30, 2025 | 41.30 Mn |
| Jun 30, 2025 | -110.10 Mn |
| Jun 30, 2025 | -110.10 Mn |
| Mar 31, 2025 | 125.40 Mn |
| Mar 31, 2025 | 125.40 Mn |
| Dec 31, 2024 | -291.70 Mn |
| Dec 31, 2024 | -291.70 Mn |
| Sep 30, 2024 | 49.80 Mn |
| Sep 30, 2024 | 49.80 Mn |
| Jun 30, 2024 | 72.30 Mn |
| Jun 30, 2024 | 72.30 Mn |
| Mar 31, 2024 | 109.60 Mn |
| Mar 31, 2024 | 109.60 Mn |